407 related articles for article (PubMed ID: 8523058)
1. Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer.
Moertel CG; Fleming TR; Macdonald JS; Haller DG; Laurie JA; Tangen CM; Ungerleider JS; Emerson WA; Tormey DC; Glick JH
J Clin Oncol; 1995 Dec; 13(12):2936-43. PubMed ID: 8523058
[TBL] [Abstract][Full Text] [Related]
2. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report.
Moertel CG; Fleming TR; Macdonald JS; Haller DG; Laurie JA; Tangen CM; Ungerleider JS; Emerson WA; Tormey DC; Glick JH; Veeder MH; Mailliard JA
Ann Intern Med; 1995 Mar; 122(5):321-6. PubMed ID: 7847642
[TBL] [Abstract][Full Text] [Related]
3. The addition of low-dose leucovorin to the combination of 5-fluorouracil- levamisole does not improve survival in the adjuvant treatment of Dukes' C colon cancer. IKN Colon Trial Group.
Bleeker WA; Mulder NH; Hermans J; Otter R; Plukker JT
Ann Oncol; 2000 May; 11(5):547-52. PubMed ID: 10907947
[TBL] [Abstract][Full Text] [Related]
4. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.
Haller DG; Catalano PJ; Macdonald JS; O'Rourke MA; Frontiera MS; Jackson DV; Mayer RJ
J Clin Oncol; 2005 Dec; 23(34):8671-8. PubMed ID: 16314627
[TBL] [Abstract][Full Text] [Related]
5. Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma.
Scheithauer W; Kornek GV; Marczell A; Karner J; Salem G; Greiner R; Burger D; Stöger F; Ritschel J; Kovats E; Vischer HM; Schneeweiss B; Depisch D
Br J Cancer; 1998 Apr; 77(8):1349-54. PubMed ID: 9579845
[TBL] [Abstract][Full Text] [Related]
6. A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancer.
Kelsen DP; Saltz L; Cohen AM; Yao TJ; Enker W; Tong W; Tao Y; Bertino JR
Cancer; 1994 Oct; 74(8):2224-33. PubMed ID: 7922973
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III.
Taal BG; Van Tinteren H; Zoetmulder FA;
Br J Cancer; 2001 Nov; 85(10):1437-43. PubMed ID: 11720425
[TBL] [Abstract][Full Text] [Related]
8. 5-Fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer: long-term follow-up results of the adjCCA-01 trial.
Arkenau HT; Bermann A; Rettig K; Strohmeyer G; Porschen R;
Ann Oncol; 2003 Mar; 14(3):395-9. PubMed ID: 12598344
[TBL] [Abstract][Full Text] [Related]
9. Fluorouracil plus leucovorin as effective adjuvant chemotherapy in curatively resected stage III colon cancer: results of the trial adjCCA-01.
Porschen R; Bermann A; Löffler T; Haack G; Rettig K; Anger Y; Strohmeyer G;
J Clin Oncol; 2001 Mar; 19(6):1787-94. PubMed ID: 11251010
[TBL] [Abstract][Full Text] [Related]
10. Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer.
O'Connell MJ; Laurie JA; Kahn M; Fitzgibbons RJ; Erlichman C; Shepherd L; Moertel CG; Kocha WI; Pazdur R; Wieand HS; Rubin J; Vukov AM; Donohue JH; Krook JE; Figueredo A
J Clin Oncol; 1998 Jan; 16(1):295-300. PubMed ID: 9440756
[TBL] [Abstract][Full Text] [Related]
11. Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project C-04.
Wolmark N; Rockette H; Mamounas E; Jones J; Wieand S; Wickerham DL; Bear HD; Atkins JN; Dimitrov NV; Glass AG; Fisher ER; Fisher B
J Clin Oncol; 1999 Nov; 17(11):3553-9. PubMed ID: 10550154
[TBL] [Abstract][Full Text] [Related]
12. Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
Poplin EA; Benedetti JK; Estes NC; Haller DG; Mayer RJ; Goldberg RM; Weiss GR; Rivkin SE; Macdonald JS
J Clin Oncol; 2005 Mar; 23(9):1819-25. PubMed ID: 15774775
[TBL] [Abstract][Full Text] [Related]
13. Leucovorin and fluorouracil vs levamisole and fluorouracil as adjuvant chemotherapy in rectal cancer.
Tsavaris N; Gennatas K; Kosmas C; Skopelitis HM; Gouveris P; Dimitrakopoulos A; Zacharakis M; Kouraklis G; Vasiliou J; Felekouras E; Voros D; Zografos G; Balafouta M; Paraskevaidis M; Safioleas M; Fotiadis K; Papastratis G; Karatzas G; Papalambros E
Oncol Rep; 2004 Oct; 12(4):927-32. PubMed ID: 15375524
[TBL] [Abstract][Full Text] [Related]
14. A systematic overview of chemotherapy effects in colorectal cancer.
Ragnhammar P; Hafström L; Nygren P; Glimelius B;
Acta Oncol; 2001; 40(2-3):282-308. PubMed ID: 11441937
[TBL] [Abstract][Full Text] [Related]
15. The role of levamisole in the adjuvant treatment of stage III colon cancer patients: a randomized trial of 5-fluorouracil and levamisole versus 5-fluorouracil alone.
Cascinu S; Catalano V; Piga A; Mattioli R; Marcellini M; Pancotti A; Bascioni R; Torresi U; Silva RR; Pieroni V; Giorgi F; Catalano G; Cellerino R
Cancer Invest; 2003; 21(5):701-7. PubMed ID: 14628428
[TBL] [Abstract][Full Text] [Related]
16. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04).
Mamounas E; Wieand S; Wolmark N; Bear HD; Atkins JN; Song K; Jones J; Rockette H
J Clin Oncol; 1999 May; 17(5):1349-55. PubMed ID: 10334518
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemotherapy for patients with resected Dukes' C and high-risk B2 colon cancer with fluorouracil and levamisole.
Au E; Ang PT; Seow-Choen F; Soo KC; Low CH; Chng HC; Ng BK
Ann Acad Med Singap; 1998 Sep; 27(5):733-7. PubMed ID: 9919352
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC).
Di Costanzo F; Sobrero A; Gasperoni S; Dogliotti L; Frassineti L; Falcone A; Lionetto R; Bruzzi P; Luppi G; Gallo L; Conte P; Comandone A; Turci D; Marzola M; Folco U; Pfanner E; Mestriner M; Boni C; Galli C; Tonato M; Rosso R;
Ann Oncol; 2003 Sep; 14(9):1365-72. PubMed ID: 12954574
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant sequential methotrexate --> 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer.
Sobrero A; Frassineti G; Falcone A; Dogliotti L; Rosso R; Di Costanzo F; Bruzzi P;
Br J Cancer; 2005 Jan; 92(1):24-9. PubMed ID: 15611795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]